Related Experiment Video

Updated: Jun 24, 2026

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

Ovarian juvenile granulosa cell tumors in infants

Moisés Leyva-Carmona1, M Angeles Vázquez-López, Francisco Lendinez-Molinos

  • 1Department of Pediatrics, Hospital Torrecárdenas, Almeria, Spain. moisesleyva@hotmail.com

Journal of Pediatric Hematology/Oncology
|April 7, 2009
PubMed

Insights

Juvenile ovarian granulosa cell tumors (JGCTs) are rare in children, especially infants. This study details two infant cases, one with recurrent bilateral JGCT and another with Ollier disease, revising diagnostic and treatment approaches.

Area of Science:

  • Pediatric Oncology
  • Gynecologic Pathology

Background:

  • Juvenile ovarian granulosa cell tumors (JGCTs) are rare neoplasms in pediatric patients.
  • While often benign, JGCTs can exhibit late recurrences, necessitating prolonged follow-up.

Observation:

  • Presents two unique cases of JGCT in infants.
  • Case 1: Late recurrence of bilateral JGCT in an infant.
  • Case 2: JGCT in a newborn diagnosed with Ollier disease.

Findings:

  • Highlights the exceptional occurrence of JGCTs in prepubertal infants.
  • Demonstrates the potential for recurrence even in very young patients.
  • Associates JGCT with rare conditions like Ollier disease in neonates.

Implications:

  • Emphasizes the need for heightened clinical suspicion for JGCTs in infants.
  • Suggests revised diagnostic and therapeutic strategies for pediatric JGCTs.
  • Underscores the importance of long-term surveillance for recurrent juvenile ovarian tumors.

Related Concept Videos

Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
Ovaries01:26

Ovaries

The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of cuboidal...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...